In vitro activities of anidulafungin and other antifungal agents against biofilms formed by clinical isolates of different Candida and Aspergillus species

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 6, 2011, Pages 3031-3035

  Fiori, Barbara ^a   Posteraro, Brunella ^a   Torelli, Riccardo ^a   Tumbarello, Mario ^a   Perlin, David S ^b   Fadda, Giovanni ^a   Sanguinetti, Maurizio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; BIOFILM; BLOOD CULTURE; BROTH DILUTION; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CENTRAL VENOUS CATHETER; FUNGUS ISOLATION; IN VITRO STUDY; LUNG LAVAGE; MINIMUM INHIBITORY CONCENTRATION; NASAL BIOPSY; NONHUMAN; PLANKTON; PRIORITY JOURNAL; PROPHYLAXIS; SKIN CULTURE; SPUTUM CULTURE; TISSUE;

ANTIFUNGAL AGENTS; ASPERGILLUS; BIOFILMS; CANDIDA; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; MICROBIAL SENSITIVITY TESTS;

EID: 79956297405     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01569-10     Document Type: Article

References (28)

1. Al-Fattani, M. A., and L. J. Douglas. 2004. Penetration of Candida biofilms by antifungal agents. Antimicrob. Agents Chemother. 48:3291-3297.
2. Angiolella, L., et al. 2008. Increase of virulence and its phenotypic traits in drug-resistant strains of Candida albicans. Antimicrob. Agents Chemother. 52:927-936.
3. Beauvais, A., et al. 2007. An extracellular matrix glues together the aerial-grown hyphae of Aspergillus fumigatus. Cell. Microbiol. 9:1588-1600.
4. Choi, H. W., et al. 2007. Species-specific differences in the susceptibilities of biofilms formed by Candida bloodstream isolates to echinocandin antifungals. Antimicrob. Agents Chemother. 51:1520-1523.
5. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard, 2nd ed., M38-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Hasan, F., I. Xess, X. Wang, N. Jain, and B. C. Fries. 2009. Biofilm formation in clinical Candida isolates and its association with virulence. Microbes Infect. 11:753-761.
8. Jacobson, M. J., K. E. Piper, G. Nguyen, J. M. Steckelberg, and R. Patel. 2008. In vitro activity of anidulafungin against Candida albicans biofilms. Antimicrob. Agents Chemother. 52:2242-2243.
9. Katragkou, A., et al. 2008. Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms. Antimicrob. Agents Chemother. 52:357-360.
10. Kuhn, D. M., J. Chandra, P. K. Mukherjee, and M. A. Ghannoum. 2002. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect. Immun. 70:878-888.
11. Kuhn, D. M., T. George, J. Chandra, P. K. Mukherjee, and M. A. Ghannoum. 2002. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob. Agents Chemother. 46:1773-1780.
12. Loussert, C., et al. 2010. In vivo biofilm composition of Aspergillus fumigatus. Cell. Microbiol. 12:405-410.
13. Mermel, L. A., et al. 2009. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin. Infect. Dis. 49:1-45.
14. Messer, S. A., R. N. Jones, G. J. Moet, J. T. Kirby, and M. Castanheira. 2010. Potency of anidulafungin compared to nine other antifungal agents tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: results from the global SENTRY Antimicrobial Surveillance Program (2008). J. Clin. Microbiol. 48:2984-2987.
15. Mowat, E., J. Butcher, S. Lang, C. Williams, and G. Ramage. 2007. Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus. J. Med. Microbiol. 56:1205-1212.
16. Mowat, E., et al. 2008. Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms. J. Antimicrob. Chemother. 62:1281-1284.
17. Müller, F. M., M. Seidler, and A. Beauvais. 2011. Aspergillus fumigatus biofilms in the clinical setting. Med. Mycol. 49(Suppl. 1):S96-S100. [Epub ahead of print.]
18. Nett, J. E., H. Sanchez, M. T. Cain, and D. R. Andes. 2010. Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan. J. Infect. Dis. 202:171-175.
19. Paderu, P., et al. 2007. Serum differentially alters the antifungal properties of echinocandin drugs. Antimicrob. Agents Chemother. 51:2253-2256.
20. Perlin, D. S. 2007. Resistance to echinocandin-class antifungal drugs. Drug Resist. Updat. 10:121-130.
21. Pierce, C. G., et al. 2008. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat. Protoc. 3:1494-1500.
22. Ramage, G., E. Mowat, B. Jones, C. Williams, and J. Lopez-Ribot. 2009. Our current understanding of fungal biofilms. Crit. Rev. Microbiol. 35:340-355.
23. Seidler, M., S. Salvenmoser, and F. M. Müller. 2008. Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells. Antimicrob. Agents Chemother. 52:4130-4136.
24. Seidler, M., S. Salvenmoser, and F. M. Müller. 2010. Liposomal amphotericin B eradicates Candida albicans biofilm in a continuous catheter flow model. FEMS Yeast Res. 10:492-495.
25. Shuford, J. A., K. E. Piper, J. M. Steckelberg, and R. Patel. 2007. In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates. Diagn. Microbiol. Infect. Dis. 57:277-281.
26. Tumbarello, M., et al. 2007. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J. Clin. Microbiol. 45:1843-1850.
27. Vediyappan, G., T. Rossignol, and C. d'Enfert. 2010. Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans. Antimicrob. Agents Chemother. 54:2096-2111.
28. Walker, L. A., N. A. Gow, and C. A. Munro. 2010. Fungal echinocandin resistance. Fungal Genet. Biol. 47:117-126.